IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 33 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $320,000 | -3.0% | 300,000 | 0.0% | 0.00% | – |
| Q1 2019 | $330,000 | +17.9% | 300,000 | 0.0% | 0.00% | – |
| Q4 2018 | $280,000 | -28.0% | 300,000 | 0.0% | 0.00% | – |
| Q3 2018 | $389,000 | -2.3% | 300,000 | 0.0% | 0.00% | – |
| Q2 2018 | $398,000 | +12.7% | 300,000 | 0.0% | 0.00% | – |
| Q1 2018 | $353,000 | +1.7% | 300,000 | 0.0% | 0.00% | – |
| Q4 2017 | $347,000 | -61.3% | 300,000 | -60.3% | 0.00% | -100.0% |
| Q3 2017 | $897,000 | -49.6% | 755,000 | -43.2% | 0.00% | -50.0% |
| Q2 2017 | $1,779,000 | -23.1% | 1,330,000 | -28.5% | 0.00% | 0.0% |
| Q1 2017 | $2,312,000 | -4.5% | 1,860,000 | -12.1% | 0.00% | 0.0% |
| Q4 2016 | $2,420,000 | -46.2% | 2,115,000 | -43.9% | 0.00% | -50.0% |
| Q3 2016 | $4,494,000 | -3.8% | 3,770,000 | -17.3% | 0.00% | -20.0% |
| Q2 2016 | $4,671,000 | – | 4,560,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,000,000 | $1,164,000 | 0.58% |
| CSS LLC/IL | 7,044,000 | $8,236,000 | 0.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $39,039,000 | 0.45% |
| DeepCurrents Investment Group LLC | 5,056,000 | $5,872,000 | 0.26% |
| SSI INVESTMENT MANAGEMENT LLC | 3,175,000 | $3,696,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $5,850,000 | 0.17% |
| LINDEN ADVISORS LP | 10,269,000 | $12,015,000 | 0.14% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,817,000 | $2,126,000 | 0.11% |
| HBK INVESTMENTS L P | 10,116,000 | $11,822,000 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 16,000,000 | $18,783,000 | 0.03% |